ライフサイエンスコーパス: pancreatic cyst

1 h pancreatic cysts, 158 (55.8%) had only one pancreatic cyst.

2 ghty-three (19.6%) patients had at least one pancreatic cyst.

3 l is effective for the treatment of mucinous pancreatic cysts.

4 s emerged as an adjunct to the assessment of pancreatic cysts.

5 lance after 5 years for patients with stable pancreatic cysts.

6 differentiating between benign and malignant pancreatic cysts.

7 the evaluation of diagnostically challenging pancreatic cysts.

8 % and a positive predictive value of 75% for pancreatic cysts.

9 dy from the pool without reported incidental pancreatic cysts.

10 ing in differentiating malignant from benign pancreatic cysts.

11 graphy is the preferred imaging modality for pancreatic cysts.

12 lind trial of 39 patients with mucinous-type pancreatic cysts.

13 treatment and strategies for surveillance of pancreatic cysts.

14 number of patients are being diagnosed with pancreatic cysts.

15 ential clinical utility in the evaluation of pancreatic cysts.

16 reased identification of small, asymptomatic pancreatic cysts.

17 gy records were reviewed for the presence of pancreatic cysts.

18 oblastomas, pheochromocytomas, and renal and pancreatic cysts.

19 Of 283 patients with pancreatic cysts, 158 (55.8%) had only one pancreatic cy

20 percentages of male and female patients with pancreatic cysts (20.4% vs 18.8%) were not significantly

21 cancer 4), 23 serous cystadenomas, 13 other pancreatic cysts, 27 pancreatic endocrine tumors, 16 chr

22 y than control subjects to have at least one pancreatic cyst (40 of 110 patients [36%] vs 25 of 110 c

23 More than 2% of adults harbor a pancreatic cyst, a subset of which progresses to invasiv

24 hol is not required for effective EUS-guided pancreatic cyst ablation, and when alcohol is removed fr

25 ne whether alcohol is required for effective pancreatic cyst ablation, if removing alcohol from the a

26 between collected variables and presence of pancreatic cysts among patients with ADPKD.

27 nitial computed tomography (CT) revealing no pancreatic cyst and subsequent follow-up MR imaging depi

28 and pancreatic cancer, in the evaluation of pancreatic cysts and choledocholithiasis, and in perform

29 eflect the pathophysiological development of pancreatic cysts and diabetes.

30 ntral nervous system, renal cell carcinomas, pancreatic cysts and tumors, pheochromocytomas, endolymp

31 se-positive CT (4 chronic pancreatitis and 1 pancreatic cyst) and 18 false-negative CT (all with true

32 ,039 CT or MR scans, 290 patients (1.2%) had pancreatic cysts, and 168 of these patients (0.7%) had n

33 ledocholithiasis, extrinsic compression from pancreatic cysts, and cholangitis), and 3 with bile leak

34 s, abnormal left-right axis, hepatorenal and pancreatic cysts, and embryonic lethality.

35 pathology, current management guidelines for pancreatic cysts, and integration of DNA-based molecular

36 of acute pancreatitis, chronic pancreatitis, pancreatic cysts, and pancreatic cancer in the general p

37 Pancreatic cysts are a clinical quandary in both diagnos

38 Hepatic and pancreatic cysts are also common.

39 Because pancreatic cysts are becoming more frequently diagnosed,

40 Pancreatic cysts are best evaluated by a team of healthc

41 noma and high-grade dysplasia among mucinous pancreatic cysts are clinically needed.

42 rotein Bicaudal-C (Bicc1) provokes renal and pancreatic cysts as well as ectopic Wnt/beta-catenin sig

43 ter smaller than 10 mm-is similar to that of pancreatic cysts at autopsy and higher than that of panc

44 The prevalence of pancreatic cysts at single-shot fast SE MR imaging-espec

45 tic cysts at autopsy and higher than that of pancreatic cysts at transabdominal ultrasonography.

46 70 years old or older are now diagnosed with pancreatic cysts, but it is not clear which ones require

47 that subjects with CEL-MODY develop multiple pancreatic cysts by the time they develop diabetes and t

48 of MR imaging examination were evaluated for pancreatic cysts by using axial and coronal single-shot

49 sis of pancreatic cancer, the detection of a pancreatic cyst can be a source of anxiety for both the

50 Management of pancreatic cysts can be guided using novel Markov-based

51 osine monophosphate-activated kinase (AMPK), pancreatic cyst development was independent of AMPK sign

52 enocarcinoma remotely at the location of the pancreatic cyst diagnosed 11 months prior.

53 Incremental improvements in pancreatic cyst diagnosis have occurred with new biomark

54 patients with asymptomatic small incidental pancreatic cysts (diameter, 5-20 mm) with two or more ma

55 , increase of MPD diameter, absence of extra pancreatic cysts, elevated serum CA19-9 levels, and elev

56 The natural history and management of pancreatic cysts, especially for branch duct intraductal

57 The cellular content of pancreatic cyst fluid aspirate is often suboptimal for a

58 agnostic utility of amphiregulin (AREG) as a pancreatic cyst fluid biomarker to differentiate non-muc

59 trospective study to evaluate AREG levels in pancreatic cyst fluid by ELISA from 33 patients with a h

60 nalysis of DNA mutations and proteins within pancreatic cyst fluid have identified potential biomarke

61 tic tumor tissues as well as in premalignant pancreatic cyst fluids.

62 The PPV of small pancreatic cysts for prediction of benignity was 87% (75

63 Incidental pancreatic cysts found by using CT or MR imaging are ass

64 Incidental pancreatic cysts had a hazard ratio of 3.0 (95% CI confi

65 Sixteen (5.7%) patients with pancreatic cysts had malignant pancreatic tumors, and 75

66 uencing and targeted sequencing of the major pancreatic cysts has identified unique mutational profil

67 ternational guidelines for the management of pancreatic cysts have been developed over the past decad

68 he diagnosis and management of patients with pancreatic cysts have progressed significantly in recent

69 difficult to detect malignancy in neoplastic pancreatic cysts; however, a detailed cyst fluid analysi

70 agnetic resonance (MR) imaging prevalence of pancreatic cysts in a cohort of patients with autosomal

71 s of experience) who were trained to measure pancreatic cysts in a similar manner.

72 We identified multiple pancreatic cysts in all eight diabetic mutation carriers

73 f asymptomatic HRIs frequently detects small pancreatic cysts, including curable, noninvasive high-gr

74 The prevalence of pancreatic cysts increased with age (r = 0.96).

75 eneralized fat necrosis, due to rupture of a pancreatic cyst into the portal vein, occurred in a 57-y

76 Accurate diagnosis of the nature of pancreatic cysts is challenging but more important than

77 Although the overall rate of malignant pancreatic cysts is low, it remains higher than the gene

78 d to 1 of 2 groups that underwent EUS-guided pancreatic cyst lavage with either 80% ethanol (control)

79 Pancreatic cysts may be intraductal mucinous neoplasms,

80 these patients is complex, and knowledge of pancreatic cyst natural history and predictors of neopla

81 nts whose CT or MR imaging showed incidental pancreatic cysts; no-cyst cohort was three-to-one freque

82 ignificantly associated with the presence of pancreatic cysts (P = .0004) and with liver volume (P =

83 y of patients, asymptomatic small incidental pancreatic cysts remained stable during a median follow-

84 Diagnosis of pancreatic cysts remains challenging due to limitations

85 The management of pancreatic cysts requires risk stratification for malign

86 hibit extrahepatic manifestations, including pancreatic cysts, splenomegaly, and common bile duct dil

87 herefore, we recommend surgical excision for pancreatic cysts that are increasing under observation,

88 of a computerized search, 510 patients with pancreatic cysts that had been detected at computed tomo

89 ural history, and predictors of neoplasia in pancreatic cysts to determine which patients can safely

90 uated the yield of continued surveillance of pancreatic cysts up to and after 5 years of follow up.

91 elationship between mortality and incidental pancreatic cysts varied by age: hazard ratios were 1.40

92 aintained registry of patients evaluated for pancreatic cysts was queried (1995-2016).

93 Patients with ADPKD and a pancreatic cyst were 5.9 times more likely to have a PKD

94 and January 2005 for the ICD-9 diagnosis of pancreatic cyst were reviewed.

95 The majority (n = 75) of small pancreatic cysts were benign.

96 Thirty-one consecutive patients with pancreatic cysts were enrolled in the study.

97 Pancreatic cysts were evaluated in 539 patients.

98 2:58) with 370 asymptomatic small incidental pancreatic cysts were included.

99 In a univariate analysis, pancreatic cysts were more prevalent in patients with AD

100 Conclusion Pancreatic cysts were more prevalent in patients with AD

101 ine phosphatase levels, and absence of extra pancreatic cysts were predictors of invasiveness.

102 , three on chronic pancreatitis, and none on pancreatic cysts) were identified, with a total study po

103 The images were reviewed for presence of pancreatic cysts, which were classified as simple and no